Recombinant Human Tumor Necrosis Factor Receptor (P75) Fc Fusion Protein (Tnfr: Fc) in Rheumatoid Arthritis
Open Access
- 1 November 1997
- journal article
- review article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 31 (11), 1335-1338
- https://doi.org/10.1177/106002809703101111
Abstract
BACKGROUND:Tumor necrosis factor (TNF) is the dominant mediator of the cytokine cascade that causes inflammation and joint destruction in rheumatoid arthritis. A new class of agents under investiga... OBJETIVO:El factor de necrosis de tumor (FNT) es el mediador más dominante en la cascada de atocinas, que causa inflamación y destrucción de coyunturas en artritis reumatoidea. Una nueva clase de a...Keywords
This publication has 18 references indexed in Scilit:
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997
- Guidelines for the management of rheumatoid arthritisArthritis & Rheumatism, 1996
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Soluble tumor necrosis factor receptors in human inflammatory synovial fluidsArthritis & Rheumatism, 1993
- Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesArthritis & Rheumatism, 1992
- Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1992
- TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?Rheumatology, 1992
- Comparison of auranofin, methotreaxate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trialArthritis & Rheumatism, 1992
- Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid ArthritisArthritis & Rheumatism, 1991
- Tumor Necrosis FactorScientific American, 1988